EUVIMEDEUVIMED entdecken
Crossref

Clinician Perspectives on Cardiovascular Risk–Based Use of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes Mellitus in Indian Settings

S Manjula

Advances in Diabetes & Endocrinology · 2026 · 9 (1)

DOI: 10.13188/2475-5591.1000025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Diabetes & Endocrinology, 2026. Verfasst von S Manjula.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Manjula, S. (2026). Clinician Perspectives on Cardiovascular Risk–Based Use of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes Mellitus in Indian Settings. Advances in Diabetes & Endocrinology, 9(1). https://doi.org/10.13188/2475-5591.1000025

Vancouver

Manjula S. Clinician Perspectives on Cardiovascular Risk–Based Use of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes Mellitus in Indian Settings. Advances in Diabetes & Endocrinology. 2026;9(1). doi:10.13188/2475-5591.1000025

BibTeX
@article{Manjula2026,
  author = {Manjula, S},
  title = {Clinician Perspectives on Cardiovascular Risk–Based Use of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes Mellitus in Indian Settings},
  journal = {Advances in Diabetes & Endocrinology},
  year = {2026},
  volume = {9},
  number = {1},
  doi = {10.13188/2475-5591.1000025}
}
Kostenlos starten →